John B. Thomas
Corporate Officer/Principal bei NIRI NY Chapter
Aktive Positionen von John B. Thomas
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NIRI NY Chapter | Corporate Officer/Principal | - | - |
Karriereverlauf von John B. Thomas
Ehemalige bekannte Positionen von John B. Thomas
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Investor Relations Kontakt | 01.05.2015 | 01.01.2017 |
| ABBOTT LABORATORIES | Investor Relations Kontakt | 01.12.1995 | 01.05.2013 |
| Public Communications Contact | 01.12.1995 | 01.05.2013 | |
| Abbott Fund | Präsident | - | - |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Investor Relations Kontakt | 17.04.2018 | - |
| Public Communications Contact | 17.04.2018 | - | |
| University of Mississippi | Corporate Officer/Principal | - | - |
Ausbildung von John B. Thomas
| University of Mississippi | Undergraduate Degree |
| Lake Forest Graduate School of Management | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 7 |
| Irland | 2 |
Operativ
| Investor Relations Contact | 3 |
| Public Communications Contact | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
| NIRI NY Chapter | |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
| Abbott Fund |
- Börse
- Insiders
- John B. Thomas
- Erfahrung
